The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Achillion Pharmaceuticals Inc | COM | 00448Q201 | 40,698 | 13,749,383 | SH | SOLE | 1, 2 | 13,749,383 | 0 | 0 | |
Adverum Biotechnologies Inc | COM | 00773U108 | 32,786 | 6,256,840 | SH | SOLE | 1, 2 | 6,256,840 | 0 | 0 | |
Agenus Inc | COM NEW | 00847G705 | 29,353 | 9,883,213 | SH | SOLE | 1, 2 | 9,883,213 | 0 | 0 | |
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 78,112 | 835,873 | SH | SOLE | 1, 2 | 835,873 | 0 | 0 | |
Anchiano Therapeutics Ltd | SPONSORED ADS | 03280X102 | 411 | 60,414 | SH | SOLE | 1, 2 | 60,414 | 0 | 0 | |
Apyx Med Corp | COM | 03837C106 | 19,718 | 3,124,899 | SH | SOLE | 1, 2 | 3,124,899 | 0 | 0 | |
Arbutus Biopharma Corp | COM | 03879J100 | 19,727 | 5,510,223 | SH | SOLE | 1, 2 | 5,510,223 | 0 | 0 | |
argenx SE | SPONSORED ADR | 04016X101 | 3,834 | 30,714 | SH | SOLE | 1, 2 | 30,714 | 0 | 0 | |
Arrowhead Pharmaceuticals In | COM | 04280A100 | 28,043 | 1,528,213 | SH | SOLE | 1, 2 | 1,528,213 | 0 | 0 | |
Arvinas Inc | COM | 04335A105 | 13,528 | 916,514 | SH | SOLE | 1, 2 | 916,514 | 0 | 0 | |
Axonics Modulation Tech Inc | COM | 05465P101 | 36,501 | 1,524,030 | SH | SOLE | 1, 2 | 1,524,030 | 0 | 0 | |
Axsome Therapeutics Inc | COM | 05464T104 | 8,476 | 595,635 | SH | SOLE | 1, 2 | 595,635 | 0 | 0 | |
Bristol Myers Squibb Co | COM | 110122108 | 72,780 | 1,525,464 | SH | SOLE | 1, 2 | 1,525,464 | 0 | 0 | |
CareDx Inc | COM | 14167L103 | 6,987 | 221,663 | SH | SOLE | 1, 2 | 221,663 | 0 | 0 | |
Chardan Healthcare Acquisiti | UNIT 12/13/2023 | 15957A207 | 6,018 | 600,000 | SH | SOLE | 1, 2 | 600,000 | 0 | 0 | |
Concert Pharmaceuticals Inc | COM | 206022105 | 20,380 | 1,688,448 | SH | SOLE | 1, 2 | 1,688,448 | 0 | 0 | |
Cytomx Therapeutics Inc | COM | 23284F105 | 10,376 | 965,252 | SH | SOLE | 1, 2 | 965,252 | 0 | 0 | |
Dicerna Pharmaceuticals Inc | COM | 253031108 | 91,167 | 6,223,036 | SH | SOLE | 1, 2 | 6,223,036 | 0 | 0 | |
Electrocore inc | COM | 28531P103 | 3,626 | 518,010 | SH | SOLE | 1, 2 | 518,010 | 0 | 0 | |
Establishment Labs Hldgs Inc | COM | G31249108 | 31,866 | 1,325,539 | SH | SOLE | 1, 2 | 1,325,539 | 0 | 0 | |
Fluidigm Corp del | COM | 34385P108 | 25,662 | 1,930,934 | SH | SOLE | 1, 2 | 1,930,934 | 0 | 0 | |
Homology Medicines Inc | COM | 438083107 | 48,159 | 1,736,719 | SH | SOLE | 1, 2 | 1,736,719 | 0 | 0 | |
Johnson & Johnson | COM | 478160104 | 11,828 | 84,614 | SH | SOLE | 1, 2 | 84,614 | 0 | 0 | |
La Jolla Pharmaceutical Co | COM PAR $.0001 2 | 503459604 | 1,936 | 301,166 | SH | SOLE | 1, 2 | 301,166 | 0 | 0 | |
LivaNova PLC | SHS | G5509L101 | 42,317 | 435,136 | SH | SOLE | 1, 2 | 435,136 | 0 | 0 | |
Masimo Corp | COM | 574795100 | 50,274 | 363,569 | SH | SOLE | 1, 2 | 363,569 | 0 | 0 | |
Mirati Therapeutics Inc | COM | 60468T105 | 22,876 | 312,093 | SH | SOLE | 1, 2 | 312,093 | 0 | 0 | |
Motus Gi hldgs Inc | COM | 62014P108 | 1,792 | 459,478 | SH | SOLE | 1, 2 | 459,478 | 0 | 0 | |
Myokardia Inc | COM | 62857M105 | 36,735 | 706,570 | SH | SOLE | 1, 2 | 706,570 | 0 | 0 | |
Myriad Genetics Inc | COM | 62855J104 | 8,881 | 267,491 | SH | SOLE | 1, 2 | 267,491 | 0 | 0 | |
Neuronetics Inc | COM | 64131A105 | 2,540 | 166,561 | SH | SOLE | 1, 2 | 166,561 | 0 | 0 | |
Odonate Therapeutics Inc | COM | 676079106 | 7,324 | 331,240 | SH | SOLE | 1, 2 | 331,240 | 0 | 0 | |
Oncocyte Corporation | COM | 68235C107 | 5,091 | 1,288,873 | SH | SOLE | 1, 2 | 1,288,873 | 0 | 0 | |
Optinose Inc | COM | 68404V100 | 851 | 82,645 | SH | SOLE | 1, 2 | 82,645 | 0 | 0 | |
Orthopediatrics Corp | COM | 68752L100 | 18,937 | 428,142 | SH | SOLE | 1, 2 | 428,142 | 0 | 0 | |
Principia Biopharma Inc | COM | 74257L108 | 15,502 | 455,948 | SH | SOLE | 1, 2 | 455,948 | 0 | 0 | |
ProQR Thrapeutics N V | SHS EURO | N71542109 | 51,637 | 3,722,950 | SH | SOLE | 1, 2 | 3,722,950 | 0 | 0 | |
PTC Therapeutics Inc | COM | 69366J200 | 94,637 | 2,514,271 | SH | SOLE | 1, 2 | 2,514,271 | 0 | 0 | |
Regenxbio Inc | COM | 75901B107 | 25,857 | 451,182 | SH | SOLE | 1, 2 | 451,182 | 0 | 0 | |
Rocket Pharmaceuticals Inc | COM | 77313F106 | 280,250 | 16,037,486 | SH | SOLE | 1, 2 | 16,037,486 | 0 | 0 | |
Sarepta Therapeutics Inc | COM | 803607100 | 40,310 | 338,199 | SH | SOLE | 1, 2 | 338,199 | 0 | 0 | |
Si bone Inc | COM | 825704109 | 23,912 | 1,269,194 | SH | SOLE | 1, 2 | 1,269,194 | 0 | 0 | |
Solid Biosciences Inc | COM | 83422E105 | 1,305 | 141,836 | SH | SOLE | 1, 2 | 141,836 | 0 | 0 | |
Translate Bio Inc | COM | 89374L104 | 13,787 | 1,352,970 | SH | SOLE | 1, 2 | 1,352,970 | 0 | 0 | |
Uniqure NV | SHS | N90064101 | 9,190 | 154,058 | SH | SOLE | 1, 2 | 154,058 | 0 | 0 | |
Vericel Corp | COM | 92346J108 | 43,564 | 2,487,922 | SH | SOLE | 1, 2 | 2,487,922 | 0 | 0 | |
Viewray Inc | COM | 92672L107 | 1,177 | 159,247 | SH | SOLE | 1, 2 | 159,247 | 0 | 0 | |
Viveve Med Inc | COM NEW | 92852W204 | 4,211 | 4,480,565 | SH | SOLE | 1, 2 | 4,480,565 | 0 | 0 | |
Vivus Inc 4.5 05/01/2020 | NOTE 4.500% 5/0 | 928551AA8 | 3,120 | 4,000,000 | SH | SOLE | 1 | 4,000,000 | 0 | 0 | |
WAVE Life Sciences Ltd | SHS | Y95308105 | 16,969 | 436,777 | SH | SOLE | 1, 2 | 436,777 | 0 | 0 |